Convexity Scientific announced today that the company launched its Flyp nebulizer for patients with asthma and chronic obstructive pulmonary disease.
The handheld, pocket-sized device was approved by the FDA in May last year. Convexity’s nebulizer includes a vibrating internal disk that produces an inhaled aerosol mist to deliver medication deep into patients’ lungs.
The device is powered by a rechargeable lithium-ion battery and can last for 10 treatments on a single charge, according to the company.
“Flyp is literally breathing new life into the nebulizer market by offering physicians a solution that puts convenience, portability and busy lifestyles at the forefront of how they treat patients with debilitating respiratory conditions, without compromising efficacy or patient outcomes,” CEO Jim Daniels said in prepared remarks.
“For patients suffering from asthma, COPD and other lung-related diseases, Flyp offers a convenient and effective alternative to preventing and managing flare-ups,” co-founder & chairman Dr. Ralph Finger, who invented the Flyp device, added. “For years, the patient has been asked to fit their life to their nebulizer. Now with Flyp, there’s a nebulizer that fits into their life.”
